ANDA 74953, held by Sandoz. Clomipramine Hydrochloride.
As of Nov 16, 2026, ANDA 74953 (Clomipramine Hydrochloride), held by Sandoz, was first approved by FDA on Jun 25, 1997, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 25, 1997 | Original application | Approved | None posted |
| Clomipramine Hydrochloride25MG · capsule;oral | Clomipramine Hydrochloride | Rx |
| Clomipramine Hydrochloride50MG · capsule;oral | Clomipramine Hydrochloride | Rx |
| Clomipramine Hydrochloride75MG · capsule;oral | Clomipramine Hydrochloride | Rx |
| Jun 2, 2020 | Supplement 3Labeling · Standard review | Approved | None posted |
| Jun 2, 2020 | Supplement 6Labeling · Standard review | Approved | None posted |
| Nov 20, 1998 | Supplement 1Manufacturing | Approved | None posted |
| Jun 25, 1997 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters